{"title": "Association between 2019-nCoV transmission and N95 respirator use", "doi": "10.1101/2020.02.18.20021881", "citation_id": "2020.02.18.20021881v1", "date": "2020-02-19", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.18.20021881", "abstract": "<p>2019-nCoV had caused pneumonia outbreak in Wuhan. Existing evidence have confirmed the human-to-human transmission of 2019-nCoV. We retrospectively collected infection data from 2 January to 22 January at six departments from Zhongnan Hospital of Wuhan University. In our study, we found N95 respirators, disinfection and hand washing can help to reduce the risk of 2019-nCoV infection in medical staffs. Our results call for re-emphasizing strict occupational protection code in battling this novel contagious disease. The risk of 2019-nCoV infection was higher in the open area than in the quarantined area. N95 may be more effective for 2019-nCoV infections.</p>", "twitter_description": "2019-nCoV had caused pneumonia outbreak in Wuhan. Existing evidence have confirmed the human-to-human transmission of 2019-nCoV. We retrospectively collected infection data from 2 January to 22 January at six departments from Zhongnan Hospital of Wuhan University. In our study, we found N95 respirators, disinfection and hand washing can help to reduce the risk of 2019-nCoV infection in medical staffs. Our results call for re-emphasizing strict occupational protection code in battling this novel contagious disease. The risk of 2019-nCoV infection was higher in the open area than in the quarantined area. N95 may be more effective for 2019-nCoV infections.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis study was supported in part by grants from the Medical Science Advancement Program (Clinical Medicine) of Wuhan University (TFLC2018002). \n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nN/A", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20021881v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20021881v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20021881v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/19/2020.02.18.20021881.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.18.20021881v1", "access_rights": "restricted", "authors": ["Xinghuan Wang", "Zhenyu Pan", "Zhenshun Cheng"]}